Oncomark

Oncomark is a leading biotechnology research company focused on the development and application of innovative biomarker panels, significantly contributing to oncology drug development. Oncomark excels in bridging the gap between -omic level discovery and validation, employing multiplex antibody-based assays and high-throughput tissue microarray screening. This commitment ensures the delivery of precise and reliable results, aiding in the advancement of cancer therapies.

Oncomark's dedication extends to in-house research and development, creating unique multi-marker assays designed to discriminate patient response to various drug therapies. The company also applies a novel in-house image analysis toolkit for assessing IHC-based markers at the subcellular compartmental level [IHC-MARK]. These advancements offer substantial benefits to the pharmaceutical and health authority sectors, enhancing the precision and effectiveness of treatment strategies.

Located primarily at Belfield, Dublin, IE, Oncomark continues to drive progress in the field of biotechnology. Oncomark is committed to pushing the boundaries of scientific knowledge and providing valuable tools for improving patient outcomes. We invite the manager of Oncomark to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative contributions.